ATRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline ABSI Q1 2026 Earnings EPS Beats Estimates Amid Continued Drug Discovery Progress Sweetgreen SG Q1 2026 Earnings EPS Misses Estimates Stock Rallies 891 ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains VRTS Q1 2026 Earnings EPS Misses Estimates on Negative Surprise Traws Pharma Inc TRAW Q1 2026 Earnings BetterthanExpected Losses Highlight Cost Discipline Amid PreRevenue Phase